Skip to main content

#156506

Anti-Human Ataxin-3 [4B8]

Cat. #156506

Anti-Human Ataxin-3 [4B8]

Cat. #: 156506

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Ataxin-3

Class: Monoclonal

Application: ELISA ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Patrick Loll

Institute: Drexel University

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Human Ataxin-3 [4B8]
  • Alternate name: Machado-Joseph Disease (MJD) Protein 1; Spinocerebellar Ataxia Type 3
  • Research fields: Biochemistry;Neurobiology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Purpose: Marker
  • Conjugation: Unconjugated
  • Cell signalling pathway: PI3K signalling
  • Molecular weight: 42 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IP
  • Description: Ataxin-3 is a deubiquitinating enzyme involved in the clearance of misfolded proteins. The enzyme functions in proteasome degradation and autophagy. Mutated forms of Ataxin-3 can lead to misfolded protein aggregation which cause the neurodegenerative disorder spinocerebellar ataxia type-3 (SCA3), also known as Machado-Joseph disease.
  • Immunogen: Recombinant Human Ataxin-3
  • Immunogen uniprot id: ATX3_HUMAN
  • Recommended controls: IgG1 kappa

Target Details

  • Target: Ataxin-3
  • Molecular weight: 42 kDa
  • Tissue cell line specificity: Mouse
  • Target background: Ataxin-3 is a deubiquitinating enzyme involved in the clearance of misfolded proteins. The enzyme functions in proteasome degradation and autophagy. Mutated forms of Ataxin-3 can lead to misfolded protein aggregation which cause the neurodegenerative disorder spinocerebellar ataxia type-3 (SCA3), also known as Machado-Joseph disease.

Applications

  • Application: ELISA ; IP

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.